Amylyx reveals data from Phase III LUCIDITY trial of avexitide
Amylyx Pharmaceuticals has reported the data behind a Phase III trial win for its investigational glucagon-like peptide-1 (GLP-1) receptor antagonist…
Amylyx Pharmaceuticals has reported the data behind a Phase III trial win for its investigational glucagon-like peptide-1 (GLP-1) receptor antagonist…